Health & Science

From obscurity to a Nobel Prize nomination: Houston scientists acclaimed for their patent-free COVID-19 vaccine

Corbevax, a low-cost coronavirus vaccine created in Houston, could be a better weapon against COVID-19 by reaching the unvaccinated in poorer countries.


Maria Bottazzi replaces vials of the RBD-based SARS-CoV-2 vaccine into a freezer at the Tropical Medicine Lab at Texas Children’s Hospital Center for Vaccine Development in Houston on Oct. 5, 2021.

No patent means lower cost

"We need to see the data"

Flipping the script

Reaching the global population

Today in Houston Newsletter Signup
We're in the process of transitioning services for our Today in Houston newsletter. If you'd like to sign up now, fill out the form below and we will add you as soon as we finish the transition. **Please note** If you are already signed up for the newsletter, you do not need to sign up again. Your subscription will be migrated over.